Anixa Biosciences Stock Forecast for 2023 - 2025 - 2030
Updated on 02/04/2023
Anixa Biosciences Stock Forecast and Price Target
The average target price set lately by experts for Anixa Biosciences to reach by the end of the year is $11.00, which would imply a potential upside of approximately 150.57 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $11.00 and a low estimate of $11.00. If you are interested in ANIX stock, you should also look at its competitors.
150.57% Upside
Anixa Biosciences Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Anixa Biosciences's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $4.75, which would mean an increase of 100.00%. Over the next eight years, experts predict that Anixa Biosciences's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$111.79 | $120.97 | 11.82% |
| BDX Stock Forecast | Becton, Dickinson and | Outperform |
17
|
$245.84 | $268.00 | 11.86% |
| MARA Stock Forecast | Marathon Digital Holdings | Outperform |
11
|
$7.07 | $63.75 | 175.81% |
| QTRH Stock Forecast | Quarterhill | Outperform |
8
|
C$1.98 | C$3.45 | 64.14% |
| VHC Stock Forecast | VirnetX Holding Corp | - |
6
|
$1.73 | $36.00 | 39.88% |
Anixa Biosciences Revenue Forecast for 2023 - 2025 - 2030
In the last year, Anixa Biosciences's Revenue has grown by 104.00%, rising from $250.00k to $510.00k. According to 0 analysts, Anixa Biosciences's Revenue will fall by 50.98% in the next year, reaching $250.00k. Professionals believe that By 2030, Anixa Biosciences's Revenue will fall to $421.24k – a 17.40% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| AWH Stock Forecast | Aspira Women's Health | Buy |
7
|
$0.49 | $0.00 | 512.24% |
| NTIP Stock Forecast | Network-1 Technologies | - |
-2
|
$2.23 | $0.00 | 15.70% |
| DSS Stock Forecast | Document Security Systems | Buy |
0
|
$0.42 | $0.00 | 423.81% |
Anixa Biosciences Free Cash Flow Forecast for 2023 - 2025 - 2030
Anixa Biosciences's Free Cash Flow has grown In the last year, rising from $-4.92M to $-6.20M – a growth of 26.02%. For the following year, the 0 analysts predict that Anixa Biosciences's Free Cash Flow will drop by 20.65%, reaching $-4.92M. In 2030, the professionals' prediction is that ANIX's Free Cash Flow will decrease by 11.93%, reaching $-5.46M.
Anixa Biosciences Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Anixa Biosciences's Net Income has grown, rising from $-11.65M to $-13.60M – a growth of 16.74%. 0 analysts predict Anixa Biosciences's Net Income will decrease by 3.71% in the next year, reaching $-13.09M. By 2030, professionals predict that Anixa Biosciences's Net Income will decrease by 7.20%, to $-12.62M.
Anixa Biosciences EBITDA Forecast for 2023 - 2025 - 2030
Anixa Biosciences's EBITDA has seen impressive growth In the last two years, rising from $-11.00M to $-13.10M – a growth of 19.09%. In the following year, the 0 analysts surveyed believe that Anixa Biosciences's EBITDA will decrease by 12.02%, reaching $-11.53M. According to professionals, by 2030, Anixa Biosciences's EBITDA will have decreased by 11.08%, falling down to $-11.65M.
Anixa Biosciences EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Anixa Biosciences's EBIT has grown by 21.01%, rising from $-11.47M to $-13.88M. The next year, 0 experts forecast that Anixa Biosciences's EBIT will decrease by 5.22%, reaching $-13.16M. In 2030, professionals predict that Anixa Biosciences's EBIT will decrease by 7.82%, reaching $-12.79M.
Anixa Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Anixa Biosciences's EPS has fallen from $-0.57 to $-0.45 – a 21.05% decrease. For next year, analysts predict EPS of $-0.49, which would mean an increase of 9.11%. Over the next eight years, experts predict that Anixa Biosciences's EPS will grow at a rate of 3.83%.